back-button

    Bortezomib

    Information about Bortezomib

    Bortezomib uses

    Bortezomib is used in the treatment of Multiple myeloma and Mantle-cell lymphoma.

    How bortezomib works

    Bortezomib belongs to the class of drugs called proteasome inhibitors. Proteasomes are proteins which play an important role in growth and multiplication of cancer cells. Bortezomib blocks the action of proteasome, and reduces the growth of cancerous (actively growing) cells.
    .

    Common side effects of bortezomib

    Reduced blood platelets, Psychiatric disturbances, Vomiting, Nausea, Loss of appetite, Fever, Anemia, Diarrhoea, Peripheral neuropathy (tingling and numbness of feet and hand), Decreased appetite, Low energy, Decreased white blood cell count (neutrophils), Constipation

    Available Medicine for Bortezomib

    • ₹12500 to ₹12688
      Natco Pharma Ltd
      2 variant(s)
    • ₹13125 to ₹18522
      Dr Reddy's Laboratories Ltd
      2 variant(s)
    • ₹15852
      Emcure Pharmaceuticals Ltd
      1 variant(s)
    • ₹15864
      Intas Pharmaceuticals Ltd
      1 variant(s)
    • ₹15201
      Cadila Pharmaceuticals Ltd
      1 variant(s)
    • ₹11904
      Panacea Biotec Ltd
      1 variant(s)
    • ₹12218
      Pfizer Ltd
      1 variant(s)
    • ₹12696
      Zuventus Healthcare Ltd
      1 variant(s)
    • ₹3999 to ₹12020
      Glenmark Pharmaceuticals Ltd
      2 variant(s)
    • ₹11308
      RPG Life Sciences Ltd
      1 variant(s)

    Expert advice for Bortezomib

    • Before taking bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.
    • Drink plenty of fluids every day during your treatment with bortezomib.
    • Tell your doctor if you are or planning to become pregnant or are breastfeeding.
    • Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.
    • Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.

    Frequently asked questions for Bortezomib

    Bortezomib

    Q. Is Bortezomib a chemotherapy/hormonal drug/ cytotoxic?
    Bortezomib is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
    Q. How does Bortezomib work?
    Bortezomib belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
    Q. Is Bortezomib FDA approved?
    Yes, Bortezomib is approved by FDA
    Show More
    Q. Is Bortezomib dialyzable?
    Yes, Bortezomib is dialyzable
    Q. Is Bortezomib toxic?
    Bortezomib can cause toxic effects if not given in appropriate dose although not everybody gets them
    Q. Does Bortezomib cause constipation?
    Bortezomib may cause side effects such as constipation.

    Content on this page was last updated on 05 April, 2017, by Dr. Varun Gupta (MD Pharmacology)